investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Gene and cell ↓3.72   Pharmaceutical  ↓2.67   Disease: Metabolic disorders ↓2.67 «See more»   Disease: Central nervous system (CNS) ↑0.63   Immunology ↑6.42   Disease: Addictions ↑6.42

Disease: Central nervous system (CNS) stock segment: trending tickers

CYCN Cyclerion Therapeutics, Inc. - Common Stock 25.37% 25.37% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1755237/000095017024054602/0000950170-24-054602-index.htm
10-Q - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock -3.35% -3.35% 0 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/0001689548-24-000073-index.htm
8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)
+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock 0.00% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1553643/000121390024024022/0001213900-24-024022-index.htm
8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock 6.42% 6.42% 0 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1430306/000199937124007476/0001999371-24-007476-index.htm
8-K/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
+ My List
TRVN Trevena, Inc. - Common Stock 0.00% 0 + Biopharma, Medicine, Disease: Central nervous system (CNS)

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1429560/000155837024008209/0001558370-24-008209-index.htm
10-Q - TREVENA INC (0001429560) (Filer)
+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock -4.08% -4.08% 0 + Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1806310/000095017024059555/0000950170-24-059555-index.htm
10-Q - Taysha Gene Therapies, Inc. (0001806310) (Filer)
+ My List
TTNP Titan Pharmaceuticals, Inc. - Common Stock -6% -6% 0 + Biopharma, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/910267/000182912624002193/0001829126-24-002193-index.htm
8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)
+ My List
VTGN VistaGen Therapeutics, Inc. - Common Stock -3.69% -3.69% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1411685/000141168524000023/0001411685-24-000023-index.htm
8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
+ My List
RVPH Reviva Pharmaceuticals Holdings, Inc. - Common Stock -2.67% -2.67% 0 + Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/0001437749-24-018540-index.htm
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
+ My List
DRUG Bright Minds Biosciences Inc. - common stock -5.66% -5.66% 0 + Disease: Central nervous system (CNS), Biopharma, Medicine, Disease: Neurology/Alzheimer/Parkinson's

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1827401/000106299324010535/0001062993-24-010535-index.htm
6-K - BRIGHT MINDS BIOSCIENCES INC. (0001827401) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.